LivaNova PLC, a global medical technology company headquartered in London, has confirmed the appointment of Anne Liddy as its new Chief Legal Officer. The company, which specialises in cardiovascular and neuromodulation solutions, announced that Liddy will assume responsibility for its global legal, compliance, and quality assurance functions.
Ms. Liddy brings a wealth of experience to her new position, having previously served in senior legal roles within the medical technology sector. Her career includes a significant tenure at Zimmer Biomet, where she was Vice President, Chief Compliance Officer and Associate General Counsel, Global Investigations and Litigation. Prior to this, she held the position of Vice President, Chief Compliance Officer at Smith & Nephew, another prominent medical technology firm.
Her expertise spans critical areas such as global compliance, litigation, and regulatory affairs, which are increasingly vital for companies operating in the highly regulated medical device industry. The appointment is seen as a strategic move by LivaNova to strengthen its leadership in these key areas as it continues to innovate and expand its product offerings worldwide.
LivaNova's portfolio includes devices for advanced circulatory support, heart valves, and neuromodulation therapies for epilepsy and depression. The company maintains a strong focus on research and development to address unmet patient needs, with its products used in hospitals and clinics globally. The chief legal officer role is central to ensuring the company adheres to international legal frameworks and ethical standards.
The medical technology sector is a significant contributor to the UK economy, fostering innovation and providing high-value jobs. Companies like LivaNova, despite their global operations, maintain a presence and contribute to the UK's scientific and technological landscape, influencing research, development, and manufacturing capabilities within the country.